Sentence examples for markers can define from inspiring English sources

The aim of the present study is to determine if an extended immunophenotyping of lymphocytes and monocytes, including cellular activation markers, can define disease-specific patterns, and thus provide valuable diagnostic information for patients with uncharacteristic inflammatory symptoms.

The aim of the present study was to determine if an extended immunophenotyping of lymphocytes and monocytes including activation markers can define disease-specific patterns, and thus provide valuable diagnostic information for these patients.

The immune mechanisms in ASD are a promising research avenue that may result in targeted therapy, and thus, further studies are needed to identify reliable immune markers that can define the group of ASD patients likely to benefit from treatments targeting immune responses.

Our results show that the application of one molecular marker, ETS, can define most Salicornia species and genotypes.

For studies with multiple arms (i.e., resectable and unresectable groups) or multiple markers (each marker within the study can define the positivity of CTCs), each of the subgroups was considered an independent data set.

The advent of genomics and proteomics could be regarded as a natural progression from the use of only a few markers to the combination of large numbers of markers – 'tumour signatures' – that can define tumour subtypes and predict outcome.

Nevertheless, since the cause of LOAD is multifactorial [ 36], it is improbable that single (protein) markers can accurately define this complex pathology; an algorithm based on multiple biomarkers should deliver a more accurate clinical diagnosis [ 35].

An optimal partial order g* of shared markers can be defined as one from the set G minimizing the sum S (g ) = ∑ i w i min u ε U (i, g (i ) ) S i (g (i ), u ) = ∑ i w i S i (g (i ), u i (g (i ) ) ).

These data suggest that the relationship between pAKT and PTEN is complicated in invasive breast cancer, and that better understanding of the pathway is necessary before we can define the predictive markers for response to treatment with the mTOR inhibitor.

Assuming that landmark positions associated to particle are available, we can define a matched marker estimation with respect to the ground truth position as the one fulfilling.

We should explore the development of a 'consensus' read-out of large marker profiles where the composite information of multiple markers can be defined as a single parameter.